Universität zu Köln

Journal Article

Busch, Jonas, Schmidt, Stefanie, Albers, Peter, Heinzelbecker, Julia ORCID: 0000-0001-8993-7171, Kliesch, Sabine, Lackner, Julia, Pfister, David, Ruf, Christian, Winter, Christian, Zengerling, Friedemann and Beyersdorff, Dirk (2022). Can magnetic resonance imaging replace conventional computerized tomography for follow-up of patients with testicular cancer? A systematic review. World J. Urol., 40 (12). S. 2843 - 2853. NEW YORK: SPRINGER. ISSN 1433-8726

Pfister, David, Oechsle, Karin, Schmidt, Stefanie, Busch, Jonas, Bokemeyer, Carsten, Heidenreich, Axel, Heinzelbecker, Julia ORCID: 0000-0001-8993-7171, Ruf, Christian, Winter, Christian, Zengerling, Friedemann, Kliesch, Sabine, Albers, Peter and Oing, Christoph (2022). First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment A comprehensive review compiled by the German Testicular Cancer Study Group. World J. Urol., 40 (12). S. 2853 - 2862. NEW YORK: SPRINGER. ISSN 1433-8726

Winter, Christian, Zengerling, Friedemann, Busch, Jonas, Heinzelbecker, Julia ORCID: 0000-0001-8993-7171, Pfister, David, Ruf, Christian, Lackner, Julia, Albers, Peter, Kliesch, Sabine, Schmidt, Stefanie and Bokemeyer, Carsten (2022). How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence. World J. Urol., 40 (12). S. 2863 - 2879. NEW YORK: SPRINGER. ISSN 1433-8726

Zengerling, Friedemann, Beyersdorff, Dirk, Busch, Jonas, Heinzelbecker, Julia ORCID: 0000-0001-8993-7171, Pfister, David, Ruf, Christian, Winter, Christian, Albers, Peter, Kliesch, Sabine and Schmidt, Stefanie (2022). Prognostic factors in patients with clinical stage I nonseminoma-beyond lymphovascular invasion: a systematic review. World J. Urol., 40 (12). S. 2879 - 2888. NEW YORK: SPRINGER. ISSN 1433-8726

Dieckmann, Klaus-Peter, Pokrivcak, Tomas, Geczi, Lajos, Niehaus, David, Dralle-Filiz, Inken, Matthies, Cord, Dienes, Tamas, Zschaebitz, Stefanie, Paffenholz, Pia, Gschliesser, Tanja, Pichler, Renate, Mego, Michal, Bader, Pia, Zengerling, Friedemann, Heinzelbecker, Julia ORCID: 0000-0001-8993-7171, Krausewitz, Philipp, Krege, Susanne, Aurilio, Gaetano, Aksoy, Cem, Hentrich, Marcus, Seidel, Christoph, Toerzsoek, Peter, Nestler, Tim, Majewski, Matthaeus, Hiester, Andreas, Buchler, Tomas, Vallet, Sonia ORCID: 0000-0003-0146-8089, Studentova, Hana, Schoenburg, Sandra, Niedersuess-Beke, Dora, Ring, Julia, Trenti, Emanuela ORCID: 0000-0003-3034-531X, Heidenreich, Axel, Wuelfing, Christian, Isbarn, Hendrik, Pichlmeier, Uwe and Pichler, Martin (2022). Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study. Ther. Adv. Med. Oncol., 14. LONDON: SAGE PUBLICATIONS LTD. ISSN 1758-8359

Ruf, Christian G., Schmidt, Stefanie, Kliesch, Sabine, Oing, Christoph, Pfister, David, Busch, Jonas, Heinzelbecker, Julia ORCID: 0000-0001-8993-7171, Winter, Christian, Zengerling, Friedemann, Albers, Peter, Oechsle, Karin, Krege, Susanne, Lackner, Julia and Dieckmann, Klaus-Peter (2022). Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review. World J. Urol., 40 (12). S. 2889 - 2901. NEW YORK: SPRINGER. ISSN 1433-8726